- Investing Ideas
- Japanese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Japanese Pharmaceuticals & Biotech Potentially Undervalued Small Caps
Results
4
Value score of at least 4 focused on companies with a low market cap.
4 companies
PhoenixBio
Market Cap: JP¥1.4b
Provides contract testing services for medical product development in Japan, the United States, and internationally.
6190
JP¥343.00
7D
0.9%
1Y
-14.2%
Kidswell Bio
Market Cap: JP¥7.2b
Develops pharmaceutical products for the treatment of pediatric, pediatric, intractable, and Asia-endemic diseases in Japan.
4584
JP¥146.00
7D
-3.3%
1Y
-44.1%
Immuno-Biological Laboratories
Market Cap: JP¥8.8b
Engages in the research, development, manufacturing, and supply of various immunological research reagents worldwide.
4570
JP¥942.00
7D
-4.8%
1Y
89.2%
WDB coco
Market Cap: JP¥6.2b
Provides contract and human resource services to pharmaceutical companies in Japan.
7079
JP¥2,569.00
7D
-1.1%
1Y
-11.9%